A carregar...
Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease
BACKGROUND: Vesicular monoamine transporter 2 (VMAT2) inhibitors can improve hyperkinetic movements, and are effective treatment options for chorea of Huntington disease (HD). Tetrabenazine was assessed for treating chorea in the TETRA-HD trial, and while efficacious, there are tolerability concerns...
Na minha lista:
| Publicado no: | J Clin Mov Disord |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5331691/ https://ncbi.nlm.nih.gov/pubmed/28265459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40734-017-0051-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|